BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30605776)

  • 21. Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD).
    Cao T; Soto A; Zhou W; Wang W; Eck S; Walker M; Harriman G; Li L
    Cell Immunol; 2009; 258(1):65-71. PubMed ID: 19410243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of third-party tolerogenic dendritic cells in the prevention of acute graft-versus-host-disease following allogeneic bone marrow transplantation in mice].
    Li GP; Yang J; Hao J; Yang YM; Ren YN; Xie RF; Fan HH; Qian KC
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):461-6. PubMed ID: 22967381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infusion of ex-vivo expanded human TCR-αβ
    Achita P; Dervovic D; Ly D; Lee JB; Haug T; Joe B; Hirano N; Zhang L
    Clin Exp Immunol; 2018 Sep; 193(3):386-399. PubMed ID: 30066399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human LAP
    Wang H; Song H; Pham AV; Cooper LJ; Schulze JJ; Olek S; Tran DQ
    Theranostics; 2019; 9(8):2315-2324. PubMed ID: 31149046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A subset of CD8+ T cells acquiring selective suppressive properties may play a role in GvHD management.
    Avivi I; Stroopinsky D; Rowe JM; Katz T
    Transpl Immunol; 2013 Jan; 28(1):57-61. PubMed ID: 23196257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human monocyte-derived suppressor cells control graft-versus-host disease by inducing regulatory forkhead box protein 3-positive CD8+ T lymphocytes.
    Janikashvili N; Trad M; Gautheron A; Samson M; Lamarthée B; Bonnefoy F; Lemaire-Ewing S; Ciudad M; Rekhviashvili K; Seaphanh F; Gaugler B; Perruche S; Bateman A; Martin L; Audia S; Saas P; Larmonier N; Bonnotte B
    J Allergy Clin Immunol; 2015 Jun; 135(6):1614-24.e4. PubMed ID: 25630940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effective expansion of alloantigen-specific Foxp3+ CD25+ CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction.
    Yamazaki S; Patel M; Harper A; Bonito A; Fukuyama H; Pack M; Tarbell KV; Talmor M; Ravetch JV; Inaba K; Steinman RM
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2758-63. PubMed ID: 16473944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High expression of Fas ligand on cord blood dendritic cells: a possible immunoregulatory mechanism after cord blood transplantation.
    Naderi N; Moazzeni SM; Pourfathollah AA; Alimoghaddam K
    Transplant Proc; 2011 Dec; 43(10):3913-9. PubMed ID: 22172872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Xenogeneic Graft-Versus-Host Disease in Humanized NSG and NSG-HLA-A2/HHD Mice.
    Ehx G; Somja J; Warnatz HJ; Ritacco C; Hannon M; Delens L; Fransolet G; Delvenne P; Muller J; Beguin Y; Lehrach H; Belle L; Humblet-Baron S; Baron F
    Front Immunol; 2018; 9():1943. PubMed ID: 30214443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells.
    Sato K; Yamashita N; Baba M; Matsuyama T
    Blood; 2003 May; 101(9):3581-9. PubMed ID: 12511411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apoptotic cell administration enhances pancreatic islet engraftment by induction of regulatory T cells and tolerogenic dendritic cells.
    Wu C; Zhang Y; Jiang Y; Wang Q; Long Y; Wang C; Cao X; Chen G
    Cell Mol Immunol; 2013 Sep; 10(5):393-402. PubMed ID: 23872920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.
    Zeng M; Guinet E; Nouri-Shirazi M
    Transpl Immunol; 2009 Dec; 22(1-2):82-92. PubMed ID: 19635560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paricalcitol (19-nor-1,25-dihydroxyvitamin D2) and calcitriol (1,25-dihydroxyvitamin D3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells.
    Sochorová K; Budinský V; Rozková D; Tobiasová Z; Dusilová-Sulková S; Spísek R; Bartůnková J
    Clin Immunol; 2009 Oct; 133(1):69-77. PubMed ID: 19660988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-10 gene-modified dendritic cells-induced type 1 T regulatory cells inhibit graft-versus-host disease while preserving graft-versus-leukemia effect.
    Wan J; Huang F; Hu W; Hao S
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):122-127. PubMed ID: 30420284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasoactive intestinal polypeptide induces regulatory dendritic cells that prevent acute graft versus host disease and leukemia relapse after bone marrow transplantation.
    Delgado M; Chorny A; Ganea D; Gonzalez-Rey E
    Ann N Y Acad Sci; 2006 Jul; 1070():226-32. PubMed ID: 16888171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of allo-antigen-specific induced Treg stabilized by vitamin C treatment and its application for prevention of acute graft versus host disease model.
    Kasahara H; Kondo T; Nakatsukasa H; Chikuma S; Ito M; Ando M; Kurebayashi Y; Sekiya T; Yamada T; Okamoto S; Yoshimura A
    Int Immunol; 2017 Dec; 29(10):457-469. PubMed ID: 29126272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human CD8+ regulatory T cells inhibit GVHD and preserve general immunity in humanized mice.
    Zheng J; Liu Y; Liu Y; Liu M; Xiang Z; Lam KT; Lewis DB; Lau YL; Tu W
    Sci Transl Med; 2013 Jan; 5(168):168ra9. PubMed ID: 23325802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin D controls the capacity of human dendritic cells to induce functional regulatory T cells by regulation of glucose metabolism.
    Vanherwegen AS; Eelen G; Ferreira GB; Ghesquière B; Cook DP; Nikolic T; Roep B; Carmeliet P; Telang S; Mathieu C; Gysemans C
    J Steroid Biochem Mol Biol; 2019 Mar; 187():134-145. PubMed ID: 30481575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation.
    Penna G; Adorini L
    J Immunol; 2000 Mar; 164(5):2405-11. PubMed ID: 10679076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Host-derived CD8⁺ dendritic cells protect against acute graft-versus-host disease after experimental allogeneic bone marrow transplantation.
    Weber M; Rudolph B; Stein P; Yogev N; Bosmann M; Schild H; Radsak MP
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1696-704. PubMed ID: 25132527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.